DE69706833D1 - Pharmazeutische zusammensetzungen enthaltend famciclovir monohydrat - Google Patents

Pharmazeutische zusammensetzungen enthaltend famciclovir monohydrat

Info

Publication number
DE69706833D1
DE69706833D1 DE69706833T DE69706833T DE69706833D1 DE 69706833 D1 DE69706833 D1 DE 69706833D1 DE 69706833 T DE69706833 T DE 69706833T DE 69706833 T DE69706833 T DE 69706833T DE 69706833 D1 DE69706833 D1 DE 69706833D1
Authority
DE
Germany
Prior art keywords
pharmaceutical compositions
compositions containing
famciclovir monohydrate
monohydrate
containing famciclovir
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69706833T
Other languages
English (en)
Other versions
DE69706833T2 (de
Inventor
Kenneth Churchill Campbell
Michael John Greenway
Stephen Andrew Hancock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis International Pharmaceutical Ltd
Original Assignee
Novartis International Pharmaceutical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9602403.9A external-priority patent/GB9602403D0/en
Priority claimed from GBGB9618494.0A external-priority patent/GB9618494D0/en
Application filed by Novartis International Pharmaceutical Ltd filed Critical Novartis International Pharmaceutical Ltd
Application granted granted Critical
Publication of DE69706833D1 publication Critical patent/DE69706833D1/de
Publication of DE69706833T2 publication Critical patent/DE69706833T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69706833T 1996-02-07 1997-02-04 Pharmazeutische zusammensetzungen enthaltend famciclovir monohydrat Expired - Fee Related DE69706833T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9602403.9A GB9602403D0 (en) 1996-02-07 1996-02-07 Pharmaceuticals
GBGB9618494.0A GB9618494D0 (en) 1996-09-05 1996-09-05 Pharmaceuticals
PCT/EP1997/000523 WO1997029108A1 (en) 1996-02-07 1997-02-04 Famciclovir monohydrate

Publications (2)

Publication Number Publication Date
DE69706833D1 true DE69706833D1 (de) 2001-10-25
DE69706833T2 DE69706833T2 (de) 2002-04-11

Family

ID=26308618

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69706833T Expired - Fee Related DE69706833T2 (de) 1996-02-07 1997-02-04 Pharmazeutische zusammensetzungen enthaltend famciclovir monohydrat

Country Status (8)

Country Link
EP (1) EP0885223B1 (de)
JP (1) JP4183750B2 (de)
AR (1) AR005730A1 (de)
AU (1) AU1601397A (de)
DE (1) DE69706833T2 (de)
ES (1) ES2165020T3 (de)
HK (1) HK1016590A1 (de)
WO (1) WO1997029108A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100369913C (zh) * 2002-08-26 2008-02-20 特瓦制药工业有限公司 Ⅰ晶型、ⅱ晶型、ⅲ晶型泛昔洛韦及其制备方法
EP1532151A2 (de) * 2002-08-26 2005-05-25 Teva Pharmaceutical Industries Limited Kristalline feste formen i, ii, iii des famciclovir and deren herstellung
JP4731121B2 (ja) * 2004-02-02 2011-07-20 協和発酵キリン株式会社 キサンチン誘導体水和物
KR20080091298A (ko) 2004-05-18 2008-10-09 테바 파마슈티컬 인더스트리즈 리미티드 결정성 고체 팜시클로버의 제조를 위한 건조방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3582399D1 (de) * 1984-09-20 1991-05-08 Beecham Group Plc Purin-derivate und ihre pharmazeutische verwendung.

Also Published As

Publication number Publication date
HK1016590A1 (en) 1999-11-05
DE69706833T2 (de) 2002-04-11
JP4183750B2 (ja) 2008-11-19
AU1601397A (en) 1997-08-28
EP0885223B1 (de) 2001-09-19
JP2000504679A (ja) 2000-04-18
EP0885223A1 (de) 1998-12-23
WO1997029108A1 (en) 1997-08-14
AR005730A1 (es) 1999-07-14
ES2165020T3 (es) 2002-03-01

Similar Documents

Publication Publication Date Title
DE69924999D1 (de) Lipasehemmer enthaltende pharmazeutische zusammensetzungen
DE69726015D1 (de) Pharmazeutische zusammensetzung enthaltend koenzym q-10
DE69525148D1 (de) Pharmazeutische formulierung
DE59712959D1 (de) Orale pharmazeutische zubereitung enthaltend ibandronat
ID24654A (id) Formulasi farmasi omeprazola
DK0938345T3 (da) Vandbaseret farmaceutisk sammensætning
ATA129892A (de) Pharmazeutische zusammensetzung
DE69807420D1 (de) Pharmazeutische aerosolzusammensetzung
CY2005007I2 (el) Φαρμακευτικες συνθεσεις που περιεχουν δαριφενακινη
DE69814091D1 (de) Voriconazol-enthaltende pharmazeutische zubereitungen
ITRM960810A0 (it) Composizioni farmaceutiche contenenti ciclosporine o macrolidi
DE4291156T1 (de) Verbesserte pharmazeutische Zusammensetzungen
ID18352A (id) Komposisi-komposisi farmasi
DE59801987D1 (de) Pharmazeutische zusammensetzung enthaltend peptichemio
DE4294862T1 (de) Pharmazeutische Komposition
DE69614407T2 (de) Pharmazeutische zusammensetzungen
DE69708130D1 (de) A-oxo-butansäuren enthaltende pharmazeutische zusammensetzung
ID16781A (id) Formulasi-formulasi farmasi
DE69830154D1 (de) Pharmazeutische zusammensetzungen
EE9800400A (et) Diklofenaaki sisaldavad farmatseutilised kompositsioonid
EE9900206A (et) N-sulfonüülindoliiniderivaate sisaldavad farmatseutilised kompositsioonid
DE69816124D1 (de) Pharmazeutische zusammensetzungen enthaltend zafirlukast
ITMI941169A0 (it) Formulazioni farmaceutiche
DE69434210D1 (de) Pharmazeutische antacidzusammensetzung
PT941100E (pt) Composicoes farmaceuticas

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

R119 Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee

Ref document number: 885223

Country of ref document: EP

Effective date: 20110901

R082 Change of representative

Ref document number: 885223

Country of ref document: EP

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN, DE